Association of common thrombophilias and antiphospholipid antibodies with success rate of in vitro fertilisation
Authors:
- 1 January 2012
- journal article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 108 (12) , 1192-1197
Abstract
Assisted reproductive technology (ART) is extensively used as a tool for pregnancy achievement in subfertile couples. Congenital and acquired thrombophilias have been suggested by some investigators to play a role in abnormal embryo implantation and placentation. The objective of this study was to assess the role of common thrombophilias in women with unexplained infertility undergoing in vitrofertilisation (IVF). We retrospectively analysed 594 women from a large healthcare maintenance organisation going through IVF and who had a thrombophilia workup, and compared them for prevalence of thrombophilia to two reference groups consisting of 637 fertile women from previous work and 17,337 women members of the same healthcare organisation with no history of venous thromboembolism. The mean age of the women at the first cycle of IVF was 30.9 years (SD: 4.1).The mean number of IVF cycles was 7.3 (SD: 5.0), and the mean fertility success rate per woman was 14.6% (SD: 19.0%). None of the common thrombophilias tested was found to be significantly associated with the number of IVF cycles or with lower fertility success rate. Rather, women who had APCR and /or factor V Leiden and lupus anticoagulant had significantly higher live birth rates (12.3% and 12.6%, respectively) in comparison to women who were tested negative (9.0% and 9.7%, respectively). Thus, hypercoagulability is not associated with failure to achieve pregnancy. These data suggest that neither screening for thrombophilia nor anticoagulant treatment is indicated in cases with unexplained reproductive failure.Keywords
This publication has 23 references indexed in Scilit:
- Multiple Hodgkin lymphoma–associated loci within the HLA region at chromosome 6p21.3Blood, 2011
- The role of low-molecular-weight heparin in recurrent implantation failure: a prospective, quasi-randomized, controlled studyFertility and Sterility, 2011
- The Association of Factor V Leiden and Prothrombin Gene Mutation and Placenta-Mediated Pregnancy Complications: A Systematic Review and Meta-analysis of Prospective Cohort StudiesPLOS Medicine, 2010
- Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trialHuman Reproduction, 2009
- Screening and treatment for heritable thrombophilia in pregnancy failure: inconsistencies among UK early pregnancy unitsBritish Journal of Haematology, 2008
- Low-molecular-weight heparin in the treatment of recurrent IVF–ET failure and thrombophilia: A prospective randomized placebo-controlled trialHuman Fertility, 2008
- Increased rates of thrombophilia in women with repeated IVF failuresHuman Reproduction, 2004
- Failures in assisted reproductive technology: an overviewEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2003
- Inherited thrombophilia and in vitro fertilization implantation failureFertility and Sterility, 2001
- Increased Frequency of Genetic Thrombophilia in Women with Complications of PregnancyNew England Journal of Medicine, 1999